Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

BetterLife Pharma Inc C.BETR

Alternate Symbol(s):  BETRF

BetterLife Pharma Inc. is a biotechnology company. The Company is primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001, which is in preclinical and is a non-hallucinogenic and non- controlled lysergic acid diethylamide (LSD) derivative in development and that is unregulated and therefore can be self-administered. Its synthesis patent for BETR-001 eliminates regulatory hurdles and its pending patent, for composition and method of use, covers treatment of major depressive disorder, anxiety disorder and neuropathic pain and other neuro-psychiatric and neurological disorders. BETR-002, which is in preclinical and is based on honokiol, the active anxiolytic ingredient of magnolia bark. Its pending method of use and formulations patent covers treatment of anxiety related disorders including benzodiazepine dependency. It also owns a drug candidate for the treatment of viral infections.


CSE:BETR - Post by User

Post by rixpixon Apr 03, 2024 12:45pm
149 Views
Post# 35968022

BETR raises $1.16 Million from convertible debentrues

BETR raises $1.16 Million from convertible debentrues
And these debentures can be converted into units.
Each unit has a 1 share and 1 warrant, both exchangeable @ 10 cents.

If the holders exchange them for shares, another 11.6 MIll shares will go into the total float.
Add another 11.6 mill shares if the warrants get exercized, increasing the total outstanding shares by over 20%. 

But If the SP is not substantially higher than 10 cents by next year, the debenture holders won't exchange it for shares and BETR will have to raise funds again so they can pay these debenture holders, watering down the already high float.

This is what I see, and all is IMHO
GLTA

<< Previous
Bullboard Posts
Next >>